期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 6, 页码 1518-1521出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm900012a
关键词
-
资金
- National Institutes of Health [5R44 CA096262-03]
Inhibition of the protein chaperone Hsp90 is a promising new approach to cancer therapy. We describe the preparation of potent non-benzoquinone ansamycins. One of these analogues, generated by feeding 3-amino-5-chlorobenzoic acid to a genetically engineered strain of Streptomyces hygroscopicus, shows high accumulation and long residence time in tumor tissue, is well-tolerated upon intravenous dosing, and is highly efficacious in the COLO205 mouse tumor xenograft model.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据